Israel China Biotechnology (ICB) Ltd Cash Flow Quality Index

Latest as of June 2021: -42.34x

Israel China Biotechnology (ICB) Ltd cash flow quality index. Israel China Biotechnology (ICB) Ltd (ICB) has a Cash Flow Quality Index of -42.34x as of June 2021. Operating cash flow of ILA-1.06 Million is below net income of ILA25.00K, suggesting accrual-heavy earnings not yet converted to cash. Explore Israel China Biotechnology (ICB) Ltd debt service capacity to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-42.34x

Operating CF / Net Income

Operating Cash Flow

ILA-1.06 Million

ILA

Net Income

ILA25.00K

ILA

Data as of

Jun 2021

Most recent filing

Israel China Biotechnology (ICB) Ltd Cash Flow Quality Index by Year (None–None)

Israel China Biotechnology (ICB) Ltd cash flow quality index by year from None to None. Year-by-year earnings quality comparison for Israel China Biotechnology (ICB) Ltd. For the full cash flow conversion analysis, see cash flow conversion of Israel China Biotechnology (ICB) Ltd.

Year	Quality Index	Operating CF (ILA)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.